🇺🇸 FDA
Patent

US 8273868

Compositions and methods for inhibiting viral replication

granted A61PA61P31/14A61P35/00

Quick answer

US patent 8273868 (Compositions and methods for inhibiting viral replication) held by Alnylam Pharmaceuticals, Inc. expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P31/14, A61P35/00